Research Article

Related GMR Articles

11/18/2013
Gene expression; Hepatocellular carcinoma; Laser capture microdissection; Microarray

The aim of this study was to identify genomic aberrations in hepatocellular carcinoma (HCC) by using laser capture microdissection (LCM) combined with microarray analysis. Samples were procured by LCM from HCC and patient-matched normal liver tissue surgically resected from 4 patients. RNA was isolated from the samples and reverse transcribed into cDNA. After 2-cycle linear amplification and 2 ... more

Y.M. Wei; Y.Y. Li; Y.C. Zhang; Y.Q. Nie
09/19/2013
Gene polymorphism; Hepatocellular carcinoma; Interleukin-28B; Liver cirrhosis; Meta-analysis; rs12979860

We examined the association of the interleukin-28B (IL-28B) gene rs12979860 T/C polymorphism with development of hepatitis virus-related hepatocellular carcinoma (HCC) and liver cirrhosis (LC). Two investigators independently searched the PubMed, Elsevier, EMBASE, Web of Science, Wiley Online Library, and Chinese National Knowledge Infrastructure data bases. Pooled odds ratios (ORs) and ... more

G.J. Suo; Z.X. Zhao
06/13/2013
Gene polymorphism; Hepatocellular carcinoma; Meta-analysis; XRCC1

XRCC1-399 allele polymorphisms have been reported to be associated with susceptibility to hepatocellular carcinoma (HCC), but the conclusions of the various studies have been inconsistent. We conducted a meta-analysis of available studies to determine whether XRCC1-399 alleles influence susceptibility to hepatocellular carcinoma. We searched English-language databases, ... more

X.Y. Zeng; J.M. Huang; J.W. Xu; Y. Xu; H.P. Yu; L. Ji; X.Q. Qiu
10/31/2014
Clinical outcome; Hepatocellular carcinoma; Polymorphism; Vascular endothelial growth factor

We conducted a cohort study to investigate the prognostic significance of vascular endothelial growth factor (VEGF) polymorphisms in hepatocellular carcinoma (HCC) patients after transcatheter arterial chemoembolization (TACE). In total, 156 patients with histologically confirmed HCC within 2 months were collected from January 2007 to January 2008. The genotypes of VEGF-2578C/A ... more

J. Song; L.Z. Wang; X. Li; T.P. Jiang; T.Z. An; M. Xu; X.P. Wu; S. Zhou
09/05/2014
HCC risk; Hepatocellular carcinoma; miR-149C>T; Polymorphisms

MicroRNAs (miRNAs) are thought to play a role in cancer development. We conducted a case-control study to investigate the association between polymorphisms in miR-149C>T and hepatocellular carcinoma (HCC) risk. Duplex polymerase chain reaction with the confronting 2-pair primers were taken to genotype miR-149C>T. The association between genotype frequencies of miR-149C>T and risk ... more

M.F. Liu; W.Q. Chen; Y.Z. He; Y.L. Gu
08/29/2014
Genetic polymorphisms; Hepatocellular carcinoma; MDR1 gene; Risk factors; susceptibility

The objective of this study was to evaluate the influence of c.1564A>T genetic polymorphisms in the multidrug resistance 1 gene (MDR1) on hepatocellular carcinoma (HCC) susceptibility through association analysis. A total of 632 HCC patients and 645 cancer-free controls were enrolled in this study. The c.1564A>T genetic polymorphisms were genotyped by created restriction ... more

Y.Y. Wan; X.W. Wang; H.X. Hui; L. Wan
07/07/2014
Asian; Hepatocellular carcinoma; Meta-analysis; Methylation; RUNX3

Runt-related transcription factor 3 (RUNX3) is a potential tumor suppressor that is frequently hypermethylated in hepatocellular carcinoma (HCC). The present meta-analysis of case-control studies was carried out to determine whether RUNX3 hypermethylation is associated with HCC. The PubMed, Embase, and Chinese National Knowledge Infrastructure databases were searched for ... more

X.X. Lu; L.Q. Zhu; F. Pang; W. Sun; C. Ou; Y. Li; J. Cao; Y.L. Hu
07/04/2014
Hepatocellular carcinoma; MicroRNA; Polymorphisms

We investigate the potential association of miR-149C>T and miR-499A>G polymorphisms and the risk of hepatocellular carcinoma (HCC). A matched case-control study of 152 cases and 304 controls were conducted. The miR-149C>T and miR-499A>G genotypes were analyzed using duplex polymerase chain reaction with restricted fragment length polymorphism. HCC patients were more likely to ... more

X.H. Wang; F.R. Wang; Y.F. Tang; H.Z. Zou; Y.Q. Zhao
05/16/2014
Clinical outcome; Hepatocellular carcinoma; Polymorphism; susceptibility; XPD; XRCC1

We explored the association between 4 XRCC1 (Arg194Trp and Arg399Gln) and XPD (Asp312Asn and Lys751Gln) polymorphisms with the development and prognosis of hepatocellular carcinoma (HCC). A total of 218 cases with HCC and 277 healthy controls were included in the study. Genotyping of the XRCC1 (Arg194Trp and Arg399Gln) and XPD (Asp312Asn and Lys751Gln) polymorphisms was ... more

J.S. Wu; Y.P. Chen; L.C. Wang; Y.J. Yang; C.W. Deng; B.X. Hou; Z.L. He; J.X. Chen
02/28/2014
Hepatocellular carcinoma; Molecular marker; Risk factors; Single nucleotide polymorphisms; XRCC1

XRCC1 (human X-ray repair complementing defective repair in Chinese hamster cell 1) gene is considered a potentially important gene influencing the risk of hepatocellular carcinoma (HCC). Our analyses detected two allelic variants of XRCC1, c.910A>G and c.1686C>G. We aimed to investigate whether these polymorphisms influence the risk of HCC. The association between ... more

W.F. Xia; X.P. Ma; X.R. Li; H. Dong; J.L. Yi

Pages